Conţinutul numărului revistei |
Articolul precedent |
Articolul urmator |
294 2 |
Ultima descărcare din IBN: 2023-08-23 11:51 |
Căutarea după subiecte similare conform CZU |
616.98:579.841-022.36-036.22 (1) |
Boli transmisibile. Boli infecţionase şi contagioase, stări febrile (575) |
Microorganisme. Bacterii (183) |
SM ISO690:2012 PRISACARI, Viorel, ANDRONACHI, Nicoleta. Studiu epidemiologic privind infecțiile nosocomiale cu Acinetobacter. In: One Health and Risk Management, 2021, nr. 2(2), pp. 36-41. ISSN 2587-3458. DOI: https://doi.org/10.38045/ohrm.2021.2.05 |
EXPORT metadate: Google Scholar Crossref CERIF DataCite Dublin Core |
One Health and Risk Management | |||||
Numărul 2(2) / 2021 / ISSN 2587-3458 /ISSNe 2587-3466 | |||||
|
|||||
DOI: https://doi.org/10.38045/ohrm.2021.2.05 | |||||
CZU: 616.98:579.841-022.36-036.22 | |||||
Pag. 36-41 | |||||
|
|||||
Descarcă PDF | |||||
Rezumat | |||||
Introduction. Acinetobacter baumannii is a pathogen and a major cause of nosocomial infections in the current healthcare system worldwide due to its high resistance to antibiotics, including those considered as a last resort, thus posing threat to severe clinical forms, as well as exhibiting significant economic and clinical impact. Material and methods. A descriptive longitudinal and cross-sectional epidemiological study was carried out based on the model of multidisciplinary care hospitals. Results. The generalized clinical forms of Acinetobacter nosocomial infections predominate in 56.30%, including: pulmonary sepsis – 25.59%, abdominal sepsis – 11.81%, septicemia – 9.45%, wound sepsis– 6.30%, biliary sepsis – 1.97%, and urosepsis – 1.18% of cases. Local infections were found in 16.93% of wound infections and in 14.57% of pneumonia cases. A. baumanii was present in the etiological structure of 98.18% of cases, exhibiting an increased resistance to antibiotics, particularly to monobactams – 100.0%, macrolides – 98.82%, penicillins – 98.08%, cephalosporins – 97.65%, penicillins with beta-lactamase inhibitors – 93.20%, fluoroquinolones – 87.16%, and amphenicols – 84.17% of cases. A. baumanii strains isolated from patients with nosocomial infections were found to be multidrug resistant to antibiotics in 93.08% of cases. Conclusions. Acinetobacter baumannii nosocomial infections represent a major public health issue that requires the implementation of strict surveillance and control strategies, including the rational use of antibiotics. |
|||||
Cuvinte-cheie Acinetobacter baumannii nosocomial infections, antibiotic resistance, infecții nosocomiale cu Acinetobacter, rezistență la antibiotice |
|||||
|